Non-pharmacological measures implemented in the setting of long-term care facilities to prevent SARS-CoV-2 infections and their consequences: a rapid review.
Journal
The Cochrane database of systematic reviews
ISSN: 1469-493X
Titre abrégé: Cochrane Database Syst Rev
Pays: England
ID NLM: 100909747
Informations de publication
Date de publication:
15 09 2021
15 09 2021
Historique:
entrez:
15
9
2021
pubmed:
16
9
2021
medline:
25
11
2021
Statut:
epublish
Résumé
Starting in late 2019, COVID-19, caused by the novel coronavirus SARS-CoV-2, spread around the world. Long-term care facilities are at particularly high risk of outbreaks, and the burden of morbidity and mortality is very high among residents living in these facilities. To assess the effects of non-pharmacological measures implemented in long-term care facilities to prevent or reduce the transmission of SARS-CoV-2 infection among residents, staff, and visitors. On 22 January 2021, we searched the Cochrane COVID-19 Study Register, WHO COVID-19 Global literature on coronavirus disease, Web of Science, and CINAHL. We also conducted backward citation searches of existing reviews. We considered experimental, quasi-experimental, observational and modelling studies that assessed the effects of the measures implemented in long-term care facilities to protect residents and staff against SARS-CoV-2 infection. Primary outcomes were infections, hospitalisations and deaths due to COVID-19, contaminations of and outbreaks in long-term care facilities, and adverse health effects. Two review authors independently screened titles, abstracts and full texts. One review author performed data extractions, risk of bias assessments and quality appraisals, and at least one other author checked their accuracy. Risk of bias and quality assessments were conducted using the ROBINS-I tool for cohort and interrupted-time-series studies, the Joanna Briggs Institute (JBI) checklist for case-control studies, and a bespoke tool for modelling studies. We synthesised findings narratively, focusing on the direction of effect. One review author assessed certainty of evidence with GRADE, with the author team critically discussing the ratings. We included 11 observational studies and 11 modelling studies in the analysis. All studies were conducted in high-income countries. Most studies compared outcomes in long-term care facilities that implemented the measures with predicted or observed control scenarios without the measure (but often with baseline infection control measures also in place). Several modelling studies assessed additional comparator scenarios, such as comparing higher with lower rates of testing. There were serious concerns regarding risk of bias in almost all observational studies and major or critical concerns regarding the quality of many modelling studies. Most observational studies did not adequately control for confounding. Many modelling studies used inappropriate assumptions about the structure and input parameters of the models, and failed to adequately assess uncertainty. Overall, we identified five intervention domains, each including a number of specific measures. Entry regulation measures (4 observational studies; 4 modelling studies) Self-confinement of staff with residents may reduce the number of infections, probability of facility contamination, and number of deaths. Quarantine for new admissions may reduce the number of infections. Testing of new admissions and intensified testing of residents and of staff after holidays may reduce the number of infections, but the evidence is very uncertain. The evidence is very uncertain regarding whether restricting admissions of new residents reduces the number of infections, but the measure may reduce the probability of facility contamination. Visiting restrictions may reduce the number of infections and deaths. Furthermore, it may increase the probability of facility contamination, but the evidence is very uncertain. It is very uncertain how visiting restrictions may adversely affect the mental health of residents. Contact-regulating and transmission-reducing measures (6 observational studies; 2 modelling studies) Barrier nursing may increase the number of infections and the probability of outbreaks, but the evidence is very uncertain. Multicomponent cleaning and environmental hygiene measures may reduce the number of infections, but the evidence is very uncertain. It is unclear how contact reduction measures affect the probability of outbreaks. These measures may reduce the number of infections, but the evidence is very uncertain. Personal hygiene measures may reduce the probability of outbreaks, but the evidence is very uncertain. Mask and personal protective equipment usage may reduce the number of infections, the probability of outbreaks, and the number of deaths, but the evidence is very uncertain. Cohorting residents and staff may reduce the number of infections, although evidence is very uncertain. Multicomponent contact -regulating and transmission -reducing measures may reduce the probability of outbreaks, but the evidence is very uncertain. Surveillance measures (2 observational studies; 6 modelling studies) Routine testing of residents and staff independent of symptoms may reduce the number of infections. It may reduce the probability of outbreaks, but the evidence is very uncertain. Evidence from one observational study suggests that the measure may reduce, while the evidence from one modelling study suggests that it probably reduces hospitalisations. The measure may reduce the number of deaths among residents, but the evidence on deaths among staff is unclear. Symptom-based surveillance testing may reduce the number of infections and the probability of outbreaks, but the evidence is very uncertain. Outbreak control measures (4 observational studies; 3 modelling studies) Separating infected and non-infected residents or staff caring for them may reduce the number of infections. The measure may reduce the probability of outbreaks and may reduce the number of deaths, but the evidence for the latter is very uncertain. Isolation of cases may reduce the number of infections and the probability of outbreaks, but the evidence is very uncertain. Multicomponent measures (2 observational studies; 1 modelling study) A combination of multiple infection-control measures, including various combinations of the above categories, may reduce the number of infections and may reduce the number of deaths, but the evidence for the latter is very uncertain. This review provides a comprehensive framework and synthesis of a range of non-pharmacological measures implemented in long-term care facilities. These may prevent SARS-CoV-2 infections and their consequences. However, the certainty of evidence is predominantly low to very low, due to the limited availability of evidence and the design and quality of available studies. Therefore, true effects may be substantially different from those reported here. Overall, more studies producing stronger evidence on the effects of non-pharmacological measures are needed, especially in low- and middle-income countries and on possible unintended consequences of these measures. Future research should explore the reasons behind the paucity of evidence to guide pandemic research priority setting in the future.
Sections du résumé
BACKGROUND
Starting in late 2019, COVID-19, caused by the novel coronavirus SARS-CoV-2, spread around the world. Long-term care facilities are at particularly high risk of outbreaks, and the burden of morbidity and mortality is very high among residents living in these facilities.
OBJECTIVES
To assess the effects of non-pharmacological measures implemented in long-term care facilities to prevent or reduce the transmission of SARS-CoV-2 infection among residents, staff, and visitors.
SEARCH METHODS
On 22 January 2021, we searched the Cochrane COVID-19 Study Register, WHO COVID-19 Global literature on coronavirus disease, Web of Science, and CINAHL. We also conducted backward citation searches of existing reviews.
SELECTION CRITERIA
We considered experimental, quasi-experimental, observational and modelling studies that assessed the effects of the measures implemented in long-term care facilities to protect residents and staff against SARS-CoV-2 infection. Primary outcomes were infections, hospitalisations and deaths due to COVID-19, contaminations of and outbreaks in long-term care facilities, and adverse health effects.
DATA COLLECTION AND ANALYSIS
Two review authors independently screened titles, abstracts and full texts. One review author performed data extractions, risk of bias assessments and quality appraisals, and at least one other author checked their accuracy. Risk of bias and quality assessments were conducted using the ROBINS-I tool for cohort and interrupted-time-series studies, the Joanna Briggs Institute (JBI) checklist for case-control studies, and a bespoke tool for modelling studies. We synthesised findings narratively, focusing on the direction of effect. One review author assessed certainty of evidence with GRADE, with the author team critically discussing the ratings.
MAIN RESULTS
We included 11 observational studies and 11 modelling studies in the analysis. All studies were conducted in high-income countries. Most studies compared outcomes in long-term care facilities that implemented the measures with predicted or observed control scenarios without the measure (but often with baseline infection control measures also in place). Several modelling studies assessed additional comparator scenarios, such as comparing higher with lower rates of testing. There were serious concerns regarding risk of bias in almost all observational studies and major or critical concerns regarding the quality of many modelling studies. Most observational studies did not adequately control for confounding. Many modelling studies used inappropriate assumptions about the structure and input parameters of the models, and failed to adequately assess uncertainty. Overall, we identified five intervention domains, each including a number of specific measures. Entry regulation measures (4 observational studies; 4 modelling studies) Self-confinement of staff with residents may reduce the number of infections, probability of facility contamination, and number of deaths. Quarantine for new admissions may reduce the number of infections. Testing of new admissions and intensified testing of residents and of staff after holidays may reduce the number of infections, but the evidence is very uncertain. The evidence is very uncertain regarding whether restricting admissions of new residents reduces the number of infections, but the measure may reduce the probability of facility contamination. Visiting restrictions may reduce the number of infections and deaths. Furthermore, it may increase the probability of facility contamination, but the evidence is very uncertain. It is very uncertain how visiting restrictions may adversely affect the mental health of residents. Contact-regulating and transmission-reducing measures (6 observational studies; 2 modelling studies) Barrier nursing may increase the number of infections and the probability of outbreaks, but the evidence is very uncertain. Multicomponent cleaning and environmental hygiene measures may reduce the number of infections, but the evidence is very uncertain. It is unclear how contact reduction measures affect the probability of outbreaks. These measures may reduce the number of infections, but the evidence is very uncertain. Personal hygiene measures may reduce the probability of outbreaks, but the evidence is very uncertain. Mask and personal protective equipment usage may reduce the number of infections, the probability of outbreaks, and the number of deaths, but the evidence is very uncertain. Cohorting residents and staff may reduce the number of infections, although evidence is very uncertain. Multicomponent contact -regulating and transmission -reducing measures may reduce the probability of outbreaks, but the evidence is very uncertain. Surveillance measures (2 observational studies; 6 modelling studies) Routine testing of residents and staff independent of symptoms may reduce the number of infections. It may reduce the probability of outbreaks, but the evidence is very uncertain. Evidence from one observational study suggests that the measure may reduce, while the evidence from one modelling study suggests that it probably reduces hospitalisations. The measure may reduce the number of deaths among residents, but the evidence on deaths among staff is unclear. Symptom-based surveillance testing may reduce the number of infections and the probability of outbreaks, but the evidence is very uncertain. Outbreak control measures (4 observational studies; 3 modelling studies) Separating infected and non-infected residents or staff caring for them may reduce the number of infections. The measure may reduce the probability of outbreaks and may reduce the number of deaths, but the evidence for the latter is very uncertain. Isolation of cases may reduce the number of infections and the probability of outbreaks, but the evidence is very uncertain. Multicomponent measures (2 observational studies; 1 modelling study) A combination of multiple infection-control measures, including various combinations of the above categories, may reduce the number of infections and may reduce the number of deaths, but the evidence for the latter is very uncertain.
AUTHORS' CONCLUSIONS
This review provides a comprehensive framework and synthesis of a range of non-pharmacological measures implemented in long-term care facilities. These may prevent SARS-CoV-2 infections and their consequences. However, the certainty of evidence is predominantly low to very low, due to the limited availability of evidence and the design and quality of available studies. Therefore, true effects may be substantially different from those reported here. Overall, more studies producing stronger evidence on the effects of non-pharmacological measures are needed, especially in low- and middle-income countries and on possible unintended consequences of these measures. Future research should explore the reasons behind the paucity of evidence to guide pandemic research priority setting in the future.
Identifiants
pubmed: 34523727
doi: 10.1002/14651858.CD015085.pub2
pmc: PMC8442144
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
CD015085Informations de copyright
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Références
Psychiatry Res. 2020 Oct;292:113369
pubmed: 32795754
Ann Intern Med. 2021 Apr;174(4):572-576
pubmed: 33085509
J Am Geriatr Soc. 2021 Jan;69(1):30-36
pubmed: 33034039
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Clin Chem Lab Med. 2020 Jun 25;58(7):1070-1076
pubmed: 32172228
JAMA. 2020 Sep 15;324(11):1103-1105
pubmed: 32790822
J Clin Epidemiol. 2019 Jul;111:105-114
pubmed: 29432858
Cochrane Database Syst Rev. 2020 Dec 17;12:CD013812
pubmed: 33331665
J Clin Epidemiol. 2017 Jul;87:4-13
pubmed: 28529184
Cochrane Database Syst Rev. 2021 Sep 15;9:CD015085
pubmed: 34523727
Cochrane Database Syst Rev. 2021 Mar 25;3:CD013717
pubmed: 33763851
J Appl Gerontol. 2021 Mar;40(3):244-256
pubmed: 33025850
J Med Eng Technol. 2020 May;44(4):169-176
pubmed: 32401550
J Appl Gerontol. 2021 Jan;40(1):3-13
pubmed: 32914668
J Clin Epidemiol. 2021 Jan;129:138-150
pubmed: 32980429
Ann Agric Environ Med. 2020 Dec 22;27(4):664-671
pubmed: 33356076
JAMA Netw Open. 2020 Aug 3;3(8):e2017533
pubmed: 32789517
Eur Heart J Qual Care Clin Outcomes. 2021 Jul 21;7(4):378-387
pubmed: 34043762
J Am Med Dir Assoc. 2020 Nov;21(11):1576-1577
pubmed: 33138941
J Gerontol A Biol Sci Med Sci. 2021 Feb 25;76(3):e19-e27
pubmed: 32738140
J Infect. 2021 Jan;82(1):159-198
pubmed: 32768449
Infect Control Hosp Epidemiol. 2020 Oct 26;:1-6
pubmed: 33100245
Psychogeriatrics. 2020 Nov;20(6):929-930
pubmed: 33067899
Euro Surveill. 2020 Jun;25(22):
pubmed: 32524949
J Am Med Dir Assoc. 2020 Nov;21(11):1568-1569
pubmed: 33138939
Sci Total Environ. 2021 Jan 15;752:141946
pubmed: 32889290
Age Ageing. 2021 Nov 10;50(6):1868-1875
pubmed: 34272866
Geriatr Gerontol Int. 2020 Oct;20(10):938-942
pubmed: 32886842
Value Health. 2014 Mar;17(2):174-82
pubmed: 24636375
Anaesthesist. 2021 Jul;70(7):582-597
pubmed: 33427914
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
J Am Med Dir Assoc. 2020 Jul;21(7):986-988.e1
pubmed: 32674833
MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1288-1295
pubmed: 32966272
CMAJ. 2020 Aug 17;192(33):E946-E955
pubmed: 32699006
J Am Med Dir Assoc. 2020 Jul;21(7):900-904
pubmed: 32674816
MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1296-1299
pubmed: 32941413
Age Ageing. 2021 Jun 28;50(4):1019-1028
pubmed: 33710281
Semergen. 2020 Aug;46 Suppl 1:35-39
pubmed: 32646731
BMJ Open. 2021 Oct 18;11(10):e047012
pubmed: 34663652
JAMA Netw Open. 2021 May 3;4(5):e2110071
pubmed: 33988707
Pflege. 2020;33(5):265-275
pubmed: 32996856
Eur Geriatr Med. 2021 Jun;12(3):601-607
pubmed: 33245505
Front Psychiatry. 2020 Sep 29;11:579842
pubmed: 33132939
F1000Res. 2017 Aug 29;6:1584
pubmed: 29552335
Acta Clin Belg. 2020 Oct 18;:1-6
pubmed: 33070766
BMC Med. 2020 Dec 8;18(1):386
pubmed: 33287821
West J Nurs Res. 2021 Sep;43(9):877-893
pubmed: 33357000
J Am Med Dir Assoc. 2020 Oct;21(10):1378-1383.e1
pubmed: 32981664
J Clin Epidemiol. 2016 Jul;75:40-6
pubmed: 27005575
J Am Med Dir Assoc. 2021 Sep;22(9):1860-1861
pubmed: 34293325
J Am Geriatr Soc. 2020 Dec;68(12):2727-2734
pubmed: 32955107
J Clin Epidemiol. 2017 Sep;89:30-42
pubmed: 28351692
J Public Health (Oxf). 2021 Jun 7;43(2):228-235
pubmed: 33367852
BMC Med. 2021 Apr 27;19(1):106
pubmed: 33902581
JAMA. 2020 Aug 18;324(7):619-620
pubmed: 32692848
Emerg Infect Dis. 2021;27(2):644-645
pubmed: 33211994
Psychiatry Res. 2020 Sep;291:113294
pubmed: 32763552
Age Ageing. 2022 Jan 6;51(1):
pubmed: 34849537
Sci Rep. 2021 Sep 10;11(1):18093
pubmed: 34508133
J Intellect Disabil Res. 2020 Sep 21;:
pubmed: 32954592
BMC Med Res Methodol. 2008 Feb 25;8:8
pubmed: 18298827
MMWR Morb Mortal Wkly Rep. 2020 Aug 28;69(34):1177-1179
pubmed: 32853190
J Am Med Dir Assoc. 2021 Feb;22(2):228-237.e25
pubmed: 33347846
Proc Natl Acad Sci U S A. 2020 Nov 24;117(47):29416-29418
pubmed: 33139561
J Health Econ. 2021 Jul;78:102475
pubmed: 34157513
J Alzheimers Dis. 2020;78(2):847-852
pubmed: 33044186
Health Aff (Millwood). 2020 Nov;39(11):1993-2001
pubmed: 32910688
Enferm Infecc Microbiol Clin (Engl Ed). 2020 Oct 20;:
pubmed: 33097294
Am J Infect Control. 2021 Apr;49(4):438-446
pubmed: 33022331
PLoS One. 2021 Apr 22;16(4):e0249588
pubmed: 33886605
J Nutr Health Aging. 2020;24(8):812-816
pubmed: 33009529
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1300-1304
pubmed: 32941409
J Pain Symptom Manage. 2020 Oct;60(4):e2-e13
pubmed: 32721500
Front Psychiatry. 2020 Sep 30;11:578465
pubmed: 33132938
Int J Geriatr Psychiatry. 2020 Dec;35(12):1449-1457
pubmed: 32892460
R Soc Open Sci. 2020 Sep 30;7(9):200880
pubmed: 33047047
J Am Med Dir Assoc. 2020 Nov;21(11):1569-1570
pubmed: 33036911
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
Res Synth Methods. 2013 Mar;4(1):95-101
pubmed: 23795209
Emerg Infect Dis. 2021 May;27(5):1288-1295
pubmed: 33900171
Enferm Clin (Engl Ed). 2021 Feb;31:S68-S72
pubmed: 32425486
J Clin Epidemiol. 2021 Feb;130:13-22
pubmed: 33068715
J Am Geriatr Soc. 2020 Nov;68(11):2447-2453
pubmed: 32930389
Alzheimers Dement. 2020 Nov;16(11):1571-1581
pubmed: 32789951
Int J Nurs Stud. 2021 Jan;113:103781
pubmed: 33080475
MMWR Morb Mortal Wkly Rep. 2021 Apr 30;70(17):639-643
pubmed: 33914720
BMJ. 2004 Jun 26;328(7455):1561-3
pubmed: 15217878
Health Technol Assess. 2021 Jun;25(39):1-74
pubmed: 34142943
PLoS Biol. 2020 Nov 12;18(11):e3000897
pubmed: 33180773
Aging Ment Health. 2021 Jul;25(7):1314-1319
pubmed: 33291991
Disabil Health J. 2020 Jul;13(3):100942
pubmed: 32473875
JAMA Intern Med. 2021 Jun 1;181(6):861-863
pubmed: 33720285
PLoS One. 2020 Nov 3;15(11):e0241536
pubmed: 33141862
Am J Geriatr Psychiatry. 2021 Nov;29(11):1101-1116
pubmed: 34266752
Biomed Res Int. 2020 Nov 4;2020:8870249
pubmed: 33204723
Lancet Healthy Longev. 2021 Mar;2(3):e129-e142
pubmed: 33655236
Front Psychiatry. 2020 Oct 26;11:585373
pubmed: 33192731
J Am Geriatr Soc. 2020 Nov;68(11):2462-2466
pubmed: 32770832
J Am Geriatr Soc. 2021 Mar;69(3):581-586
pubmed: 33370463
Nat Rev Microbiol. 2021 Mar;19(3):141-154
pubmed: 33024307
J Gerontol B Psychol Sci Soc Sci. 2021 Feb 17;76(3):e99-e103
pubmed: 32672332
Ann Geriatr Med Res. 2020 Sep;24(3):166-172
pubmed: 32752587
J Formos Med Assoc. 2020 Aug;119(8):1249-1250
pubmed: 32505590
Am J Infect Control. 2021 Jan;49(1):115-119
pubmed: 33157181
Pflege. 2020 Aug;33(4):199-206
pubmed: 32811330
Int J Geriatr Psychiatry. 2021 Jun;36(6):873-882
pubmed: 33368636
BMJ. 2020 Nov 27;371:m4509
pubmed: 33246972
J Am Med Dir Assoc. 2020 Dec;21(12):1811-1814
pubmed: 33256960
JMIR Public Health Surveill. 2020 Jul 17;6(3):e21163
pubmed: 32629425
Geriatr Psychol Neuropsychiatr Vieil. 2020 Sep 1;18(3):238-240
pubmed: 32897192
Syst Rev. 2016 Dec 5;5(1):210
pubmed: 27919275
BMJ Open. 2021 Jun 18;11(6):e048503
pubmed: 34145018
Aging Clin Exp Res. 2020 Aug;32(8):1599-1608
pubmed: 32557332
Palliat Med. 2021 May;35(5):830-842
pubmed: 33825567
J Am Med Dir Assoc. 2020 Dec;21(12):1774-1781.e2
pubmed: 33197412
J Pain Symptom Manage. 2021 Jan;61(1):e11-e19
pubmed: 33035649
JMIR Public Health Surveill. 2020 Aug 25;6(3):e20828
pubmed: 32745013
J Am Med Dir Assoc. 2021 Jan;22(1):187-192
pubmed: 33232682
J Am Psychiatr Nurses Assoc. 2021 Jan-Feb;27(1):77-82
pubmed: 33158374
MMWR Morb Mortal Wkly Rep. 2020 Aug 11;69(32):1095-1099
pubmed: 32790655
Gerontology. 2021;67(3):281-289
pubmed: 33429394
Front Psychiatry. 2020 Oct 26;11:585686
pubmed: 33192733
Clin Infect Dis. 2021 Jun 04;:
pubmed: 34086877
J Interprof Care. 2020 Sep-Oct;34(5):655-661
pubmed: 32674701
Microbes Infect. 2020 Nov - Dec;22(10):611-616
pubmed: 32977019
BMJ Glob Health. 2020 Nov;5(11):
pubmed: 33234529
J Appl Gerontol. 2021 Jan;40(1):14-17
pubmed: 32940123
Prev Med. 2021 Jul;148:106564
pubmed: 33878351
Infect Control Hosp Epidemiol. 2021 Oct;42(10):1181-1188
pubmed: 33397533
Braz J Infect Dis. 2021 Jan-Feb;25(1):101039
pubmed: 33290728
J Hosp Infect. 2021 May;111:89-95
pubmed: 33453349
Pharmacoeconomics. 2006;24(4):355-71
pubmed: 16605282
J Am Geriatr Soc. 2020 Dec;68(12):2716-2720
pubmed: 33034046
Syst Rev. 2020 Sep 25;9(1):218
pubmed: 32977848
Int Forum Allergy Rhinol. 2020 Oct;10(10):1173-1179
pubmed: 32652898
J Am Med Dir Assoc. 2020 Jul;21(7):915-918
pubmed: 32674819
BMC Public Health. 2020 Nov 30;20(1):1814
pubmed: 33256649
Iran J Public Health. 2020 Dec;49(12):2295-2307
pubmed: 34178736
Front Psychiatry. 2020 Oct 22;11:585540
pubmed: 33192732
Sci Transl Med. 2021 Jul 14;13(602):
pubmed: 34158411
BMC Infect Dis. 2020 Oct 12;20(1):745
pubmed: 33046011
HERD. 2021 Jan;14(1):130-140
pubmed: 32909834
Int J Infect Dis. 2021 Mar;104:125-131
pubmed: 33301993
Infect Control Hosp Epidemiol. 2021 Sep;42(9):1060-1070
pubmed: 33308354
PLoS One. 2020 Oct 8;15(10):e0240205
pubmed: 33031427
J Am Geriatr Soc. 2020 May;68(5):937-939
pubmed: 32293023
Clin Infect Dis. 2021 Aug 2;73(3):e792-e798
pubmed: 33564862
BMJ. 2020 Jan 16;368:l6890
pubmed: 31948937
Am J Geriatr Psychiatry. 2020 Jul;28(7):712-721
pubmed: 32331845
J Am Med Dir Assoc. 2020 Nov;21(11):1574-1576.e2
pubmed: 32994117
J Am Med Dir Assoc. 2021 Feb;22(2):257-258
pubmed: 33352194
Infect Control Hosp Epidemiol. 2021 Dec;42(12):1503-1505
pubmed: 33427153